Enable JavaScript to ensure website accessibility

Category Archives: Press Releases

Precipio Secures a short-term $500K Credit Facility

Loan will supplement any temporary cashflow deficit related to cash collections delay due to Change [...]

Precipio Announces Year end 2023 Shareholder Update Call

Conference Call to be held on April 1st, 2024 at 5:00 PM EST NEW HAVEN, [...]

Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY

Company continues to make strides towards breakeven NEW HAVEN, CT, Globenewswire – (February 13, 2024) – [...]

Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer

NEW HAVEN, CT, Globenewswire – (February 6, 2024) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: [...]

Precipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter

Results clearly demonstrate the business’s ability to reach breakeven in the near future NEW HAVEN, [...]

Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan

First order for IV-Cell placed by Major Japanese Laboratory NEW HAVEN, CT, Globenewswire – (January [...]

Precipio Announces Christina Valauri joins the Board of Directors

Douglas Fisher, MD will step down as Director, and remain as a board observer NEW [...]

Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024

NEW HAVEN, CT, Globenewswire – (December 14, 2023) – Management of specialty cancer diagnostics company Precipio, [...]

Precipio Announces Q3-2023 Shareholder Update Call

Conference Call to be held on November 20th, 2023 at 5:00 PM EST NEW HAVEN, [...]

Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022

28% Revenue Increase is Major Step toward Company Breakeven NEW HAVEN, CT, Globenewswire – (October [...]